Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 9
Review
Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,581 | Dovepress* | 12,330+ | 2,425 | 14,755 | |
PubMed Central* | 1,251 | 640 | 1,891 | ||
Totals | 13,581 | 3,065 | 16,646 | ||
*Since 15 March 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar